Zobrazeno 1 - 10
of 12
pro vyhledávání: '"BMD Nogueira"'
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, CB Machado, BMD Nogueira, AKC Machado, MEA Morais, MOM Filho, DS Oliveira, CA Moreir-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S262- (2023)
Objetivo: Atualmente, a ampla aplicação da imunofenotipagem e caracterização genética tornou-se fundamental para refinamento diagnóstico, estratificação de risco, predição de prognóstico e promoção de terapia-alvo em pacientes com Leucem
Externí odkaz:
https://doaj.org/article/396b0e483a8e432e91f1d83f3cf80645
Autor:
BMD Nogueira, FMCP Pessoa, IV Barreto, RM Ribeiro, KMC Albuquerque, DS Oliveira, GS Lopes, MEA Moraes, MOM Filho, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S308-S309 (2023)
Objetivo: A Organização Mundial da Saúde (OMS) estabeleceu em 2022 diretrizes para a estratificação de risco de pacientes adultos portadores de Leucemia Linfoblástica Aguda (LLA) de acordo com aspectos clínicos, imunofenotípicos, citogenétic
Externí odkaz:
https://doaj.org/article/09579ea065224f99afde886f627ad113
Autor:
RB Gadelha, BMD Nogueira, FMCP Pessoa, AKC Machado, IV Barreto, RM Ribeiro, GS Lopes, MEA Moraes, MOM Filho, CA Moreir-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S300-S301 (2023)
Objetivos: A classificação da leucemia mieloide aguda (LMA) é baseada principalmente nas alterações citogenéticas; Sua classificação é necessária para uma estratificação de risco, o que, por sua vez, desempenha um papel relevante no progn
Externí odkaz:
https://doaj.org/article/537cbf0ef02545f78d700d46ce68de4f
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, CB Machado, BMD Nogueira, AKC Machado, RM Ribeiro, MEA Moraes, MOM Filho, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S314- (2023)
Objetivo: Diante da importância da detecção de alterações genéticas em pacientes com leucemias, o objetivo desse estudo foi comparar a sensibilidade das técnicas Nested -PCR e RT-qPCR na detecção de alterações genéticas em pacientes porta
Externí odkaz:
https://doaj.org/article/5f4d1b8f0f9649d4b54365a66c899b3c
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, BMD Nogueira, AKC Machado, RM Ribeiro, DS Oliveira, MEA Moraes, CA Moreira-Nunes, MOM Filho
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S315- (2023)
Objetivo: Atualmente, a ampla aplicação da imunofenotipagem e caracterização genética tornou-se fundamental para refinamento diagnóstico, estratificação de risco, predição de prognóstico e promoção de terapia-alvo em pacientes com Leucem
Externí odkaz:
https://doaj.org/article/1d0e5ead36e54c88b9ab8a05972cf463
Autor:
IV Barreto, BMD Nogueira, FMCP Pessoa, RB Gadelha, AKC Machado, RM Ribeiro, APL Moreira, MEA Moraes, MOM Filho, CS Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S422-S423 (2023)
Objetivo: O mieloma múltiplo (MM) é a segunda neoplasia hematológica mais frequente no mundo, possuindo dentre seus sintomas característicos como anemia e disfunção renal. Com isso o objetivo deste trabalho é avaliar dados laboratoriais de pac
Externí odkaz:
https://doaj.org/article/2c10287aa15b41dab1c07055e0aadcae
Autor:
IV Barreto, BMD Nogueira, FMCP Pessoa, APL Moreira, GFSB Rocha, JC Medeiros, AR Maciel, MEA Moraes, MOM Filho, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S423- (2023)
Objetivo: Dentro de 45 anos o mieloma múltiplo (MM) teve um aumento em suas taxas de incidência global de 143%. Com isso, o objetivo deste trabalho é avaliar dados epidemiológicos de pacientes que chegam com suspeita de MM no Hospital Geral de Fo
Externí odkaz:
https://doaj.org/article/0b4cfc58136e46f99f23ebdcdde46b2f
Autor:
DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Nogueira BMD; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DA Costa Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Gadelha RB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Sousa Oliveira D; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Silva FAC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Gurgel LA; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Medeiros JC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., DA Rocha Maciel A; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza, CE, Brazil., Vieira RPG; Department of Hematology, São Vicente de Paulo Maternity Hospital, Barbalha, CE, Brazil., DE Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.
Publikováno v:
In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 2016-2023.
Autor:
DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Oliveira DS; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Nogueira BMD; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Albuquerque KMC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Silva FAC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Gurgel LA; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Medeiros JC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Maciel ADR; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.
Publikováno v:
Anticancer research [Anticancer Res] 2024 Jun; Vol. 44 (6), pp. 2747-2753.
Autor:
Pessoa FMCP; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Viana VBJ; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., de Oliveira MB; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., Nogueira BMD; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil., Oliveira DS; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza 60015-152, CE, Brazil., Vieira RPG; Department of Hematology, São Vicente de Paulo Maternity Hospital, Barbalha 63180-000, CE, Brazil., de Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., de Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., Moreira FC; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Central Unity, Molecular Biology Laboratory, Clementino Fraga Group, Fortaleza 60115-170, CE, Brazil.
Publikováno v:
Genes [Genes (Basel)] 2024 Jan 24; Vol. 15 (2). Date of Electronic Publication: 2024 Jan 24.